BeyondSpring Inc is engaged in clinical stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. The Company has created Plinabulin which is marine derived small-molecule with a number of distinct biological activities... BeyondSpring Inc is engaged in clinical stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. The Company has created Plinabulin which is marine derived small-molecule with a number of distinct biological activities that may provide multiple therapeutic opportunities. Plinabulin has increased the survival of neutrophils, a type of white blood cell important in the prevention of bacterial infections. The Company has a scalable business model integrating clinical resources in the United States and China. Show more
FLORHAM PARK, N.J., Sept. 16, 2024 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) (βBeyondSpringβ or the βCompanyβ), a clinical-stage global biopharmaceutical company developing innovative...
- Statistically Significant and Clinically Meaningful Efficacy Data with Favorable Benefit/Risk ratio from DUBLIN-3 Phase 3 Study of Plinabulin plus Docetaxel vs. Docetaxel in EGFR Wild-Type NSCLC...
FLORHAM PARK, N.J., Sept. 03, 2024 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) (βBeyondSpringβ or the βCompanyβ), a clinical-stage global biopharmaceutical company focused on developing...
The SEED-Eisai Research Collaboration leverages Eisaiβs leading expertise in neurodegeneration and cancer. SEED is entitled to receive upfront and milestone payments of up to $1.5 billion plus...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.225 | -9.78260869565 | 2.3 | 2.54 | 2.05 | 16285 | 2.16797718 | CS |
4 | 0.125 | 6.41025641026 | 1.95 | 2.54 | 1.86 | 27104 | 2.09417599 | CS |
12 | -0.355 | -14.6090534979 | 2.43 | 2.6 | 1.695 | 24832 | 2.09765315 | CS |
26 | -1.045 | -33.4935897436 | 3.12 | 3.75 | 1.695 | 53828 | 2.58668066 | CS |
52 | 1.3157 | 173.278019228 | 0.7593 | 4 | 0.6534 | 96988 | 2.25746963 | CS |
156 | -13.2056 | -86.420690287 | 15.2806 | 17.98 | 0.542 | 384265 | 4.54836515 | CS |
260 | -15.845 | -88.4207589286 | 17.92 | 33 | 0.542 | 458497 | 13.18819976 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.